Previous 10 | Next 10 |
PALO ALTO, Calif. , Aug. 21, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced that Phil Febbo , MD, chief medical officer (CMO) at Illumina has been appointed to the Varian Board of Directors, effective August 16, 2019 . "We are proud to have Phil Febbo join the Varian ...
PALO ALTO, Calif. , Aug. 21, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has successfully completed its asset purchase of the Boston Scientific portfolio of drug-loadable microsphere and bland embolic bead products for treating arteriovenous malformations and hypervasc...
It has been a long time since Accuray ( ARAY ) has shown any sustained momentum in the business, and it looks like the market is largely out of patience. Although the company hit an all-time high for quarterly revenue, it still can’t reliably hit the $100M/quarter order target I bel...
PALO ALTO, Calif. , Aug. 19, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced that its executive management team will be hosting an Investor Day on Friday, November 15, 2019 at The Plaza Hotel, Fifth Avenue at Central Park South, New York, NY 10019, from 8:00am to 1:00pm ...
Thesis Correct, Shorts Win I initially wrote up VRAY as a short in July of 2017 ( here ). The short thesis has played out exactly as expected with the only surprise coming from how long it took for the short to work. VRAY bulls certainly put up a good fight over the last two years but it...
PALO ALTO, Calif. , Aug. 8, 2019 /PRNewswire/ -- This afternoon, Varian (NYSE: VAR) posted a presentation providing an overview of the recently proposed radiation oncology alternative payment model and calendar year 2020 rates by the Center for Medicare & Medicaid Services. To a...
PALO ALTO, Calif. , Aug. 8, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced that its executive staff will be meeting with analysts and investors at the American Society for Radiation Oncology (ASTRO) Annual Meeting in Chicago on Monday, September 16, 2019 at 2:00 p.m. Ce...
PALO ALTO, Calif. , Aug. 5, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced that the newly proposed tariffs by the U.S. on the remaining $300 billion of Chinese imports should have no material impact to the company. Last Thursday, the U.S. announced plans to impose a 10 p...
PALO ALTO, California , July 29, 2019 /PRNewswire/ -- Following a public competitive review process, Varian (NYSE: VAR) was selected to supply its Eclipse ™ treatment planning software and ARIA ® oncology information system to three radiotherapy centers in Serbia. The V...
PALO ALTO, California and STOCKHOLM , July 25, 2019 /PRNewswire/ -- Varian (NYSE: VAR) announced that the Karolinska University Hospital Solna in Sweden is the first hospital in Scandinavia to deliver High Dose Rate (HDR) brachytherapy treatments using the new Bravos ™ afterlo...
News, Short Squeeze, Breakout and More Instantly...
Varian Medical Systems Inc. Company Name:
VAR Stock Symbol:
NYSE Market:
Varian Medical Systems Inc. Website:
Varian Announces First Participant Treated in GENESIS II Clinical Trial of Genicular Artery Embolization for Knee Osteoarthritis PR Newswire PALO ALTO, Calif. , Nov. 17, 2022 /PRNewswire/ -- Varian, a Siemens Healthineers company, announced today that the...
Varian and the Cincinnati Children's/University of Cincinnati Medical Center Proton Therapy Center Announce Promising Results from FAST-01, First-in-Human Clinical Trial of Flash Therapy PR Newswire – Results published in JAMA Oncology and presented at ASTRO dem...